Xian-Si Zeng

Dr. Xian-Si Zeng


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in ASN Neuro
Verified
Journal Article
Open access
XZXian-Si Zeng
Xian-Si Zeng
WGWen-Shuo Geng
Wen-Shuo Geng
JJJing Jia
Jing Jia
Parkinson disease (PD) is the second most common neurodegenerative movement disorder. Pharmacological animal models are invaluable tools to study the pathological mechanisms of PD. Currently, invertebrate and vertebrate animal models have been developed by using several main neurotoxins, such as 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, paraquat, and rotenone. These models achieve to some extent to reproduce the key features of PD, including motor defects, progressive loss of dopaminergic neurons in substantia nigra pars compacta, and the formation of Lewy bodies. In this review, we will highlight the pathogenic mechanisms of those neurotoxins and summarize different neurotoxic animal models with the hope to help researchers choose among them accurately and to promote the development of modeling PD.

17 April 2018 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
XZXian-Si Zeng
Xian-Si Zeng
WGWen-Shuo Geng
Wen-Shuo Geng
JJJing Jia
Jing Jia
LCLei Chen
Lei Chen
PZPeng-Peng Zhang
Peng-Peng Zhang
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in 1817. The disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although the pathogenesis of PD is still unknown, the research findings from scientists are conducive to understand the pathological mechanisms. It is well accepted that both genetic and environmental factors contribute to the onset of PD. In this review, we summarize the mutations of main seven genes (α-synuclein, LRRK2, PINK1, Parkin, DJ-1, VPS35 and GBA1) linked to PD, discuss the potential mechanisms for the loss of dopaminergic neurons (dopamine metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, impaired autophagy, and deregulation of immunity) in PD, and expect the development direction for treatment of PD.

11 May 2019 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
JJJin-Jing Jia
Jin-Jing Jia
WGWen-Shuo Geng
Wen-Shuo Geng
ZWZhan-Qi Wang
Zhan-Qi Wang
LCLei Chen
Lei Chen
XZXian-Si Zeng
Xian-Si Zeng

1 February 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
XZXian-Si Zeng
Xian-Si Zeng
JJJin-Jing Jia
Jin-Jing Jia
YKYongwon Kwon
Yongwon Kwon
SWSheng-Dong Wang
Sheng-Dong Wang
JBJie Bai
Jie Bai

13 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DBDevin M. Barry
Devin M. Barry
Xueting LiuXueting Liu
Xueting Liu
BLBenlong Liu
Benlong Liu
XLXian-Yu Liu
Xian-Yu Liu
FGFang Gao
Fang Gao
ZCZhou-Feng Chen
Zhou-Feng Chen
Gastrin-releasing peptide (GRP) functions as a neurotransmitter for non-histaminergic itch, but its site of action (sensory neurons vs spinal cord) remains controversial. To determine the role of GRP in sensory neurons, we generated a floxed Grp mouse line. We found that conditional knockout of Grp in sensory neurons results in attenuated non-histaminergic itch, without impairing histamine-induced itch. Using a Grp-Cre knock-in mouse line, we show that the upper epidermis of the skin is exclusively innervated by GRP fibers, whose activation via optogeneics and chemogenetics in the skin evokes itch- but not pain-related scratching or wiping behaviors. In contrast, intersectional genetic ablation of spinal Grp neurons does not affect itch nor pain transmission, demonstrating that spinal Grp neurons are dispensable for itch transmission. These data indicate that GRP is a neuropeptide in sensory neurons for non-histaminergic itch, and GRP sensory neurons are dedicated to itch transmission.

2 June 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
LGLiang Gong
Liang Gong
JYJiayi Yin
Jiayi Yin
YZYu Zhang
Yu Zhang
RHRen Huang
Ren Huang
YLYuxuan Lou
Yuxuan Lou
XZXian-Si Zeng
Xian-Si Zeng
Panax ginseng and Panax notoginseng, two well-known herbs with enormous medical value in Asian countries, have a long usage history in China for the therapy of some diseases, such as stroke. Ginsenoside Rb1 is one of most important active ingredients in Panax ginseng and Panax notoginseng. In the last two decades, more attention has focused on ginsenoside Rb1 as an antioxidative, anti-apoptotic and anti-inflammatory agent that can protect the nervous system. In the review, we summarize the neuroprotective roles of ginsenoside Rb1 and its potential mechanisms in central nervous system diseases (CNSDs), including neurodegenerative diseases, cerebral ischemia injury, depression and spinal cord injury. In conclusion, ginsenoside Rb1 has a potential neuroprotection due to its inhibition of oxidative stress, apoptosis, neuroinflammation and autophagy in CNSDs and may be a promising candidate agent for clinical therapy of CNSDs in the future.